Neurological Disorder Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 -2027

Mar 2020| TMR1932A| Transparency

Report Highlights

Neurological Disorder Drugs Market - Scope of the Report

TMR’s report on the global neurological disorder drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global neurological disorder drugs market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurological disorder drugs market from 2019 to 2027.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global neurological disorder drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global neurological disorder drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global neurological disorder drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurological disorder drugs market.

The report also delves into the competitive landscape of the global neurological disorder drugs market. Key players operating in the global neurological disorder drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neurological disorder drugs market that have been profiled in this report.

Key Questions Answered in Neurological Disorder Drugs Market Report

What is the sales/revenue generated by neurological disorder drugs across all regions during the forecast period?
What are the opportunities in the global neurological disorder drugs market?
What are the major drivers, restraints, opportunities, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which disorder segment is expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Neurological Disorder Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global neurological disorder drugs market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurological disorder drugs market in terms of disorder, drug class, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global neurological disorder drugs market.

  • Table 1 : Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 2 : Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 3 : Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 4 : Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 5 : North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 6 : North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 7 : North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 8 : North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 9 : Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 10 : Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 11 : Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 12 : Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 13 : Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 14 : Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 15 : Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 16 : Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 17 : Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 18 : Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 19 : Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 20 : Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 21 : Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Disorder, 2017-2027
  • Table 22 : Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017-2027
  • Table 23 : Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 24 : Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Figure 1 : Global Neurological Disorder Drugs Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
  • Figure 2 : Global Neurological Disorder Drugs Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 3 : Global Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 4 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Epilepsy, 2017-2027
  • Figure 5 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alzheimer’s Disease, 2017-2027
  • Figure 6 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parkinson’s Disease, 2017-2027
  • Figure 7 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Multiple Sclerosis, 2017-2027
  • Figure 8 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cerebrovascular Diseases, 2017-2027
  • Figure 9 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 10 : Global Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 11 : Global Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 12 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticholinergic, 2017-2027
  • Figure 13 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antiepileptic, 2017-2027
  • Figure 14 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antipsychotic, 2017-2027
  • Figure 15 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analgesic, 2017-2027
  • Figure 16 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hypnotic & Sedative, 2017-2027
  • Figure 17 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihypertensive, 2017-2027
  • Figure 18 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticoagulant, 2017-2027
  • Figure 19 : Global Neurological Disorder Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 20 : Global Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 21 : Global Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 22 : Global Neurological Disorder Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017-2027
  • Figure 23 : Global Neurological Disorder Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017-2027
  • Figure 24 : Global Neurological Disorder Drugs Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017-2027
  • Figure 25 : Global Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 26 : Global Neurological Disorder Drugs Market, by Region, 2018 and 2027
  • Figure 27 : Global Neurological Disorder Drugs Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 28 : North America Neurological Disorder Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 29 : North America Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 30 : North America Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 31 : North America Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 32 : North America Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 33 : North America Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 34 : North America Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 35 : North America Neurological Disorder Drugs Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 36 : North America Neurological Disorder Drugs Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 37 : Europe Neurological Disorder Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 38 : Europe Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 39 : Europe Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 40 : Europe Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 41 : Europe Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 42 : Europe Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 43 : Europe Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 44 : Europe Neurological Disorder Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 45 : Europe Neurological Disorder Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 46 : Asia Pacific Neurological Disorder Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 47 : Asia Pacific Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 48 : Asia Pacific Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 49 : Asia Pacific Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 50 : Asia Pacific Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 51 : Asia Pacific Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 52 : Asia Pacific Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 53 : Asia Pacific Neurological Disorder Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 54 : Asia Pacific Neurological Disorder Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 55 : Latin America Neurological Disorder Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 56 : Latin America Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 57 : Latin America Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 58 : Latin America Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 59 : Latin America Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 60 : Latin America Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 61 : Latin America Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 62 : Latin America Neurological Disorder Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 63 : Latin America Neurological Disorder Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 64 : Middle East & Africa Neurological Disorder Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 65 : Middle East & Africa Neurological Disorder Drugs Market Value Share Analysis, by Disorder, 2018 and 2027
  • Figure 66 : Middle East & Africa Neurological Disorder Drugs Market Attractiveness Analysis, by Disorder, 2019-2027
  • Figure 67 : Middle East & Africa Neurological Disorder Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027
  • Figure 68 : Middle East & Africa Neurological Disorder Drugs Market Attractiveness Analysis, by Drug Class, 2019-2027
  • Figure 69 : Middle East & Africa Neurological Disorder Drugs Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 70 : Middle East & Africa Neurological Disorder Drugs Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 71 : Middle East & Africa Neurological Disorder Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 72 : Middle East & Africa Neurological Disorder Drugs Market Attractiveness Analysis, by Country/Sub-region, 2019-2027

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report